Contract facts
FederalNo full NAICS 621511 intel page yet. Browse NAICS intelligence
NOP HEMATOLOGIC NEXT GENERATION SEQUENCING TESTING FOR THE RICHARD L ROUDEBUSH VA MEDICAL CENTER - ADD TESTING TO LINE ITEMS 2003-4003 is a federal award for 250-Network Contract Office 10 (36C250) held by Foundation Medicine, Inc. Estimated value $414K ($52K obligated). Current period of performance ends Jan 29, 2024. Last award drew 1 bidder. Place of performance: CAMBRIDGE MA.
NOP HEMATOLOGIC NEXT GENERATION SEQUENCING TESTING FOR THE RICHARD L ROUDEBUSH VA MEDICAL CENTER - ADD TESTING TO LINE ITEMS 2003-4003
Recompete timing
PublicCurrent PoP ended Jan 29, 2024 (955 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordFoundation Medicine, Inc — $67.3M obligated across 15 awards (firm-wide, all agencies).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C25020F0903?
36C25020F0903 (NOP hematologic NEXT generation sequencing) is a 250-Network Contract Office 10 (36C250) award with a potential value of $414K, currently held by Foundation Medicine, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C250-20-F-0903?
36C250-20-F-0903 is the dashed form of PIID 36C25020F0903 (NOP hematologic NEXT generation sequencing), held by Foundation Medicine, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C25020F0903?
250-Network Contract Office 10 (36C250) awarded 36C25020F0903 to Foundation Medicine, Inc (potential $414K).
Who is the incumbent on 36C25020F0903?
Foundation Medicine, Inc is the incumbent with $67.3M across 15 related awards in SCOUT’s public footprint. The current period of performance ends Jan 29, 2024.
When does Foundation Medicine, Inc’s 36C25020F0903 come up for recompete?
SCOUT tracks a period-of-performance end of Jan 29, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Seen enough? Run one full capture cycle on 36C25020F0903 — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.